Jaques-Emmanuel Galimard

39PUBLICATIONS
201CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Adolescent healthCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Sep 10, 2026
Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

|Jul 20, 2026
Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia?

|Jul 02, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

|Jun 04, 2026
Landscape Assessment to Characterize Baseline Access and Multilevel Barriers to IMProve Access to Chimeric Antigen Receptor T-Cell CD19 Therapy for Pediatric B-ALL (IMPACT study) Across Europe.

|Jun 03, 2026
Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee.

|May 19, 2026
The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in children- on behalf of PDWP/EBMT.

Pageof 7

Frequent Collaborators

16 joint publications

Mohamad Mohty

14 joint publications

Fabio Ciceri

12 joint publications

Krzysztof Kalwak

11 joint publications

Arnon Nagler